Role of IKKβ in obesity and atherosclerosis
IKKβ 在肥胖和动脉粥样硬化中的作用
基本信息
- 批准号:10008480
- 负责人:
- 金额:$ 37.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:AblationAdipocytesAdipose tissueAntisense OligonucleotidesAtherosclerosisBlood VesselsCellsChronicConsumptionCountryDevelopmentDiabetes MellitusDietDiseaseEpidemicGoalsHigh Fat DietHumanImmune responseIn VitroInflammationInflammatoryInflammatory ResponseInsulin ResistanceLinkMetabolic DiseasesMolecularMusMyelogenousNatural ImmunityObesityOvernutritionPathway interactionsPharmacologyPhosphotransferasesRegulationReportingResistanceRoleSignal TransductionSmooth Muscle MyocytesSystemTestingTherapeuticadipocyte differentiationatherogenesiscardiometabolismgain of functionin vivoinhibitor/antagonistinnovationinterestlipid biosynthesisloss of functionmacrophagemouse modelnovelnovel strategiesobesity developmentpopulation healthprecursor cellprogenitorpublic health relevanceresponsetherapeutic targetvascular inflammation
项目摘要
DESCRIPTION (provided by applicant): Obesity is associated with a state of chronic inflammation that is thought to be a major contributor to diabetes and atherosclerosis. Many inflammatory pathways that contribute to the development of insulin resistance and atherosclerosis are regulated by IKKβ/NF-κB signaling. However, the role of IKKβ in metabolic disorders and atherosclerosis remains elusive. Our initial studies showed that IKKβ deficiency (driven by a SM22Cre-IKKβ- flox system) in smooth muscle cells (SMCs) rendered mice resistant to the development of diet-induced obesity, metabolic disorders, and atherosclerosis. We made the novel finding that SM22 is expressed in primary adipose stromal vascular (SV) cells and IKKβ positively regulates adipogenesis, indicating that chronic inflammation might be an important initial trigger for the adipocyte differentiation in response to high-fat diet consumption. Our central hypothesis is that IKKβ is essential for adipogenesis and atherogenesis, and that high-fat diet-induced IKKβ activation promotes adipocyte differentiation and adipose inflammation, leading to increased obesity, insulin resistance, and atherosclerosis. Three specific aims are proposed: (1) Define the role of IKKβ in the regulation of murine and human adipocyte differentiation in response to overnutrition; (2) Determine the contribution of adipocyte IKKβ to the development of obesity-associated insulin resistance and atherosclerosis; and (3) Determine the impact of pharmacological inhibition of IKKβ by antisense oligonucleotides on diet-induced obesity and atherosclerosis. The proposed studies will define the role of IKKβ in adipogenesis and atherogenesis and will reveal a critical link between overnutrition, inflammation, and cardiometabolic disease. Our studies will also provide strong evidence for use of appropriate IKKβ inhibitors as an innovative therapeutic strategy to treat obesity and cardiometabolic disease.
描述(通过应用程序证明):肥胖症与慢性状态有关,而慢性病和动脉粥样硬化途径有助于胰岛素抵抗和动脉粥样硬化的发展。 IKKβ在代谢性疾病中的作用和动脉粥样硬化难以捉摸的n。 SM22在原发性脂肪基质血管(SV)EL和IKKβ蛇毒物质中表达,这表明慢性可能是脂肪细胞Ntiation的重要初始触发因素,以响应高脂饮食构建,促进了脂肪细胞的脂肪差异和脂肪差异。提出了肥胖,胰岛素抵抗和动脉粥样硬化的目的。 3)确定IKKβ通过药理学对IKKβ的hivation的影响。治疗肥胖和心脏代谢ASE的策略。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pregnane X Receptor Mediates Atherosclerosis Induced by Dicyclohexyl Phthalate in LDL Receptor-Deficient Mice.
- DOI:10.3390/cells11071125
- 发表时间:2022-03-26
- 期刊:
- 影响因子:6
- 作者:Liu J;Hernandez R;Li X;Meng Z;Chen H;Zhou C
- 通讯作者:Zhou C
The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease.
- DOI:10.3390/cells11111834
- 发表时间:2022-06-03
- 期刊:
- 影响因子:6
- 作者:
- 通讯作者:
Paternal phthalate exposure-elicited offspring metabolic disorders are associated with altered sperm small RNAs in mice.
- DOI:10.1016/j.envint.2023.107769
- 发表时间:2023-02
- 期刊:
- 影响因子:11.8
- 作者:Liu, Jingwei;Shi, Junchao;Hernandez, Rebecca;Li, Xiuchun;Konchadi, Pranav;Miyake, Yuma;Chen, Qi;Zhou, Tong;Zhou, Changcheng
- 通讯作者:Zhou, Changcheng
Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses.
- DOI:10.3389/fcvm.2022.841928
- 发表时间:2022
- 期刊:
- 影响因子:3.6
- 作者:Wu H;Norton V;Cui K;Zhu B;Bhattacharjee S;Lu YW;Wang B;Shan D;Wong S;Dong Y;Chan SL;Cowan D;Xu J;Bielenberg DR;Zhou C;Chen H
- 通讯作者:Chen H
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Changcheng Zhou其他文献
Changcheng Zhou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Changcheng Zhou', 18)}}的其他基金
Role of PXR in EDC-induced cardiovascular disease
PXR 在 EDC 诱发的心血管疾病中的作用
- 批准号:
10640665 - 财政年份:2023
- 资助金额:
$ 37.63万 - 项目类别:
Core D - Energy Balance and Body Composition Core
核心 D - 能量平衡和身体成分核心
- 批准号:
10225373 - 财政年份:2018
- 资助金额:
$ 37.63万 - 项目类别:
Core D - Energy Balance and Body Composition Core
核心 D - 能量平衡和身体成分核心
- 批准号:
10458566 - 财政年份:2018
- 资助金额:
$ 37.63万 - 项目类别:
Core D - Energy Balance and Body Composition Core
核心 D - 能量平衡和身体成分核心
- 批准号:
9982358 - 财政年份:2018
- 资助金额:
$ 37.63万 - 项目类别:
A novel mechanism for ART-associated dyslipidemia and atherosclerosis
ART 相关血脂异常和动脉粥样硬化的新机制
- 批准号:
9109680 - 财政年份:2015
- 资助金额:
$ 37.63万 - 项目类别:
A novel mechanism for ART-associated dyslipidemia and atherosclerosis
ART 相关血脂异常和动脉粥样硬化的新机制
- 批准号:
9273599 - 财政年份:2015
- 资助金额:
$ 37.63万 - 项目类别:
Mechanisms of atherogenic effects of bisphenol A
双酚A致动脉粥样硬化作用的机制
- 批准号:
8638093 - 财政年份:2014
- 资助金额:
$ 37.63万 - 项目类别:
Mechanisms of atherogenic effects of bisphenol A
双酚A致动脉粥样硬化作用的机制
- 批准号:
8828205 - 财政年份:2014
- 资助金额:
$ 37.63万 - 项目类别:
Endocrine disruptor mediated activation of PXR causes dyslipidemia
内分泌干扰物介导的 PXR 激活导致血脂异常
- 批准号:
8743207 - 财政年份:2013
- 资助金额:
$ 37.63万 - 项目类别:
Endocrine disruptor mediated activation of PXR causes dyslipidemia
内分泌干扰物介导的 PXR 激活导致血脂异常
- 批准号:
9308696 - 财政年份:2013
- 资助金额:
$ 37.63万 - 项目类别:
相似国自然基金
Acvrl1调控脂肪组织巨噬细胞M1/M2极化改善肥胖的机制研究
- 批准号:82300973
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
巨噬细胞介导脂肪组织重构在塑化剂干扰系统能量代谢中的作用研究
- 批准号:82373625
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
巨噬细胞GP73-CXCL5调节脂肪组织适应性产热的机制研究
- 批准号:32300573
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MYO9B缺失调控脂肪组织巨噬细胞代谢重编程促进肥胖相关胰岛素抵抗的机制研究
- 批准号:82300948
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity
饮食诱导肥胖中 ALCAT1 激活 NLRP3 的细胞机制
- 批准号:
10658507 - 财政年份:2023
- 资助金额:
$ 37.63万 - 项目类别:
Regulation of beige adipocyte plasticity in inguinal white adipose tissue.
腹股沟白色脂肪组织中米色脂肪细胞可塑性的调节。
- 批准号:
10563617 - 财政年份:2023
- 资助金额:
$ 37.63万 - 项目类别:
Mechanistic Connection between Interorganellar Communication and Obesity-associated Diseases
细胞器间通讯与肥胖相关疾病之间的机制联系
- 批准号:
10634347 - 财政年份:2023
- 资助金额:
$ 37.63万 - 项目类别:
Investigating Isthmin as an adipose-to-muscle messenger that promotes muscle protein synthesis
研究 Isthmin 作为促进肌肉蛋白质合成的脂肪到肌肉信使
- 批准号:
10664500 - 财政年份:2023
- 资助金额:
$ 37.63万 - 项目类别: